Taken together, these protein-level analyses of INPP5D in the postmortem brain suggest that full-length, aqueous-soluble INPP5D is reduced in the AD brain while truncated, C-terminus containing isoforms are elevated (Fig. 2p). The gene discussed is INPP5D; the disease is Alzheimer disease.